Literature DB >> 7024335

Epidermolysis bullosa acquisita: a heterogeneous disease.

R F Palestine, S Kossard, C H Dicken.   

Abstract

The question of whether epidermolysis bullosa acquisita (EBA) is a distinct entity prompted a review of the Mayo Clinic experience. Twelve patients with this diagnosis were seen from 1955 through 1979, and their records were reviewed. Particular attention was directed to immunofluorescence microscopy (IF), which had been performed in seven patients. Direct IF was positive in seven patients, and indirect IF was positive in four patients. Although many cases of EBA may remain distinct, we believe that the morphologic appearance known as EBA may represent a final common pathway of disease expression in a heterogeneous group of patients with a variety of more specific diseases and that trauma serves as a localizing factor. Our findings indicate that cicatricial pemphigoid probably is the most common specific diagnosis but that all cases of EBA are not represented by this diagnosis. Furthermore, we conclude that when IF is performed, exclusion of other bullous diseases, which is a key criterion for the diagnosis of EBA, is more difficult than previously recognized.

Entities:  

Mesh:

Year:  1981        PMID: 7024335     DOI: 10.1016/s0190-9622(81)70076-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Disseminated cicatricial pemphigoid in a child and in an adult. Ultrastructural diagnostic criteria and differential diagnosis with special reference to acquired epidermolysis bullosa.

Authors:  I Hausser; M Fartasch; E Schleiermacher; I Anton-Lamprecht
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

Review 2.  Alopecia in Autoimmune Blistering Diseases: A Systematic Review of Pathogenesis and Clinical Features of Disease.

Authors:  Danica Xie; Asli Bilgic-Temel; Nada Abu Alrub; Dédée F Murrell
Journal:  Skin Appendage Disord       Date:  2019-07-10

3.  Epidermolysis bullosa acquisita and total ulcerative colitis.

Authors:  B R Hughes; J Horne
Journal:  J R Soc Med       Date:  1988-08       Impact factor: 18.000

Review 4.  Autoimmunity against type VII collagen in inflammatory bowel disease.

Authors:  Gheorghe Hundorfean; Markus F Neurath; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.